News from the ACC Annual Scientific Session 2017

Letter to Readers |
March 19, 2017

News from the ACC Annual Scientific Session 2017

NEJM Journal Watch and Physician's First Watch coverage of the meeting

This week, NEJM Journal Watch and Physician's First Watch have brought you coverage of study findings presented at the American College of Cardiology's annual 2017 meeting in Washington, DC. Here is a compilation of our coverage, listed by date and title of meeting presentations, with the articles' first authors in parentheses. (Your NEJM Journal Watch subscription is required, except where noted.)

Friday, March 17, 2017

Primary Results of the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) Trial (Sabatine MS et al.)

NEJM Journal Watch coverage (free)

Transcatheter Aortic Valve Replacement with a Self-Expanding Bioprosthesis Compared with Surgical Aortic Valve Replacement in Patients at Intermediate Surgical Risk: First Results from the SURTAVI Clinical Trial (Reardon MJ et al.)

NEJM Journal Watch coverage (free)

SPIRE 1 and SPIRE 2: Safety and Cardiovascular Event Efficacy of Bococizumab Among 27,000 High Risk Patients

NEJM Journal Watch coverage (related articles by Ridker PM et al. and Roth EM et al.; free)

LDL-C Reduction From 6 to 9 Months Following Single or Second Injection of Inclisiran a Novel siRNA Compound: Primary Efficacy and Safety Outcomes of the ORION 1 Trial (Ray KK et al.)

NEJM Journal Watch coverage

Native South American Tsimane Have the Lowest Levels of Coronary Atherosclerosis Ever Reported (Kaplan H et al.)

Physician's First Watch coverage (free)

Saturday, March 18, 2017

EINSTEIN CHOICE: Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism (Weitz JI et al.)

NEJM Journal Watch coverage

A Randomized Trial Evaluating Clinically Significant Bleeding With Low-Dose Rivaroxaban Versus Aspirin, in Addition to P2Y12 Inhibition, for Patients After Acute Coronary Syndromes (Ohman EM et al.)

NEJM Journal Watch coverage

Radiation Exposure and Vascular Access in Acute Coronary Syndromes: The RAD Matrix Study (Sciahbasi A et al.)

NEJM Journal Watch coverage

Procedural and Clinical Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis (Yoon S-H et al.)

NEJM Journal Watch coverage

FFR Guided Acute Complete Revascularization Versus Culprit Lesion Only Treatment in Patients Presenting With ST-Segment Elevation Myocardial Infarction and Multi Vessel Disease: The COMPARE-ACUTE Trial (Smits PC et al.)

NEJM Journal Watch coverage

Myocarditis, Heart Failure and Arrhythmias in Patients with Zika (Gonzalez Carta KA et al.)

Physician's First Watch coverage (free)

Mortality, Length of Stay, and Cost Implications of Procedural Bleeding After Contemporary Percutaneous Interventions Involving Large-Bore Catheters (Redfors B et al.)

NEJM Journal Watch coverage

Primary Results of DEFINE-FLAIR: A Multi-Centre, Prospective, International, Randomized, Blinded Comparison of Clinical Outcomes and Cost Efficiencies of iFR and FFR Decision-Making for Physiological Guided Coronary Revascularization (Davies JE et al.)

Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve Guided Intervention (IFR-SWEDEHEART): A Multicenter, Prospective, Registry-Based Randomized Clinical Trial (Götberg M et al.)

NEJM Journal Watch coverage

Sunday, March 19, 2017

Safety and Efficacy of Uninterrupted Anticoagulation with Dabigatran Etexilate Versus Warfarin in Patients Undergoing Catheter Ablation of Atrial Fibrillation: The RE-CIRCUIT Study (Calkins H et al.)

NEJM Journal Watch coverage (free)

Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery with Cardiopulmonary Bypass: Primary Results of the LEVO-CTS Trial (Mehta RH et al.)

NEJM Journal Watch coverage

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.